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Abstract Scarformationisinfluencedbyseveralfactorssuch
as wound infection, tension, wound depth and anatomical
localization. Hypertrophic scarring is often the result of an
imbalance in the wound and scar healing process. The exact
underlying pathophysiological mechanism remains unclear.
Smoking has a higher risk of postoperative complications
probably due to a diminished macrophage induction. Follow-
ingourclinicalimpressionthatsmokerswithoutpostoperative
wound infections show esthetically better scars, we evaluated
the scars after a reduction mammaplasty in smoking and
nonsmoking patients in a prospective clinical trial. Between
July 2006 and September 2007, 13 smokers and 30 non
smokers with a reduction mammaplasty were included. They
were recruited from Viecuri Medical Centre and Atrium
Medical Centre in the Netherlands after written consent.
Surgical data and data of the patients' condition were
collected. Follow-up for erythema values of the scars was
done with a colorimeter (The Minolta CR-300, Minolta
Camera Co., Ltd., Osaka Japan) at 1, 3, 6 and 9 months
postoperatively on four standardized postsurgical sites.
ANOVA and Chi-square test were used for statistical
analysis. In the smoking group, the scars were significantly
less red compared to the nonsmoking group. No significant
differences were found in BMI, resection weight and drain
production between both groups. Although smoking is
certainly not recommended as a preventive therapy to
influence scar healing, this study confirms our assumption
that smokers tend to have faster and less erythemateous scar
healing to nonsmokers. Further research is needed to
understand the mechanism of the effect of smoking on scars.
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Introduction
Wound healing and the subsequent scar formation require
an accurate balance of inflammation [1]. Smoking is known
to result in more wound related postoperative complica-
tions, probably by disturbing the normal inflammatory
physiology. Cooperating cellular responses have to be
appropriate in several phases of wound healing. Diminished
function of the neutrophils and macrophages results in
chronic nonhealing wounds, e.g., in diabetes [2]. Hypertro-
phic scarring, on the other hand, can be the result of an
exaggerated inflammatory response. The production of
certain subspecies of TGF-β by the macrophages seems to
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discomfort such as pruritus, pain, restricted mobility and
aesthetic impairment result in a reduced quality of life [4].
Hypertrophic scars often arise after burn wounds and
appear 1 to 3 months after trauma. Our clinical impression
is that smokers, although having complicated or delayed
wound healing, almost never present with hypertrophic
scars. Therefore, we hypothesize that smoking has a
positive influence on postoperative scarring due to its effect
on the inflammatory response. To evaluate this clinical
impression, we performed a prospective patient-controlled
study comparing postoperative scar activity in smoking and
nonsmoking women undergoing a reduction mammaplasty.
Materials and methods
A double center, prospective study was performed in
female patients undergoing reduction mammaplasty. All
patients between the ages of 17 and 70 years with at least a
DD cup were included in the study. Inclusion was done
between July 2006 and September 2007 at Viecuri Medical
Centre in Venlo and Atrium Medical Centre in Heerlen,
both situated in the Netherlands. The study was approved
by the ethical committees of both hospitals and written
informed consent was obtained from each patient. Patients
were referred to the Department of Plastic Surgery by the
general practioner because of complaints of breast hyper-
trophy such as intertrigo and head, neck and/or shoulder
complaints. The indication to perform a reduction mamma-
plasty was made by the plastic surgeon. Exclusion criteria
were the presence of diabetes, skin disorders, use of
corticosteroids and immunosupressive medication, history
of keloids or hypertrophic scarring and degenerative or
metabolic disorders.
Surgery was performed by a plastic surgeon or a senior
resident using a mediocranial pedicle technique. There was
no prophylactic use of antibiotics. Data on the condition of
the patient (body mass index, age) and surgical data
(reduction weight) were collected. One day after surgery,
the patients were dismissed from the hospital. One month
postoperatively, the patient started to use a hydrating crème
on the scar. Follow-up took place at 1, 3, 6 and 9 months
after reduction mammaplasty. Dehiscence was defined as
every spontaneous disruption of the wound occurring
during the first 3 months postoperatively. Each wound
dehiscence independent of size was registered. Coloric
measurement was not performed in case of dehiscence at this
particular area. In case of clinical signs of infection (secretion,
fever, erythema), antibiotics were given. Colorimetric mea-
surement was performed under standard conditions at the
medial and lateral parts of the scar, the scar at the center of the
inframammary fold and at the nipple (at the topmost point).
Normal skin was measured at each time point in each patient
and subtracted on the values of the different sides of the scars.
Statisticalanalysiswasperformed usingANOVAwithtime
and smoking asindependent variables. Chi-square testing was
usedforstatisticalanalysisofwounddehiscencebetweenboth
groups. SPSS for Mac version 16 UK was used for analysis.
Values are presented as means ± STD.
Results
Forty-nine patients presented for reduction mammaplasty at
the two centers. Three patients were excluded because of
diabetes and/or corticosteroid use. Three other patients were
excluded because no follow-up took place during scheduled
data at the outpatient clinic. The study sample size was 43
patients.
There were 13 smokers and 30 nonsmokers in this
group. The mean age of the smokers and nonsmokers was
32.6 years (±STD12.7) and 37.4 years (±STD 13.2). There
were no differences in mean body mass index (BMI) or
resection weight between the two groups (Table 1). Anti-
biotics were given postoperatively in four patients from the
smoking group and in seven patients from the nonsmokers
because of signs of inflammation (fever, redness, pain and
edema of the breast). Silicone dressings were used in two
smoking patients and in eight nonsmokers because hydra-
tion was not sufficient and signs of hypertrophy arose.
The incidence of any postoperative dehiscence was
higher (p<0.05) in the smoking group compared to the
nonsmoking patients (69.2% versus 36.6 %, Table 1).
The redness of scars in both groups decreased over time,
mainly in the center of the inframammary fold and at the
nipple. In addition, the scars of the smokers were significantly
less red compared to the nonsmokers. This was seen at the
Table 1 Patient characteristics
*p<0.05 (statistical significance)
Nonsmokers (n=30) Smokers (n=13)
Age (years) 37.4 (STD 13.2) 32.6 (STD 12.7)
Body mass index (kg/m
2) 26.1 (STD 3.1) 26.3 (STD 3.1)
Resection weight (g) 436.8 (STD 197.3) 438.5 (STD 180.4)
Wound dehiscence (%) 36.6%
* 69.2%
*
Drain production (ml) 26,3 (STD 19.2) 22.6 (STD 20.9)
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the medial site after 3 months (p<0.005) and at the nipple
after 1 month (p=0.01) and 9 months (p<0.05) (Figs. 1–3).
At the center of the mammary fold, no significant differences
were found during the period of follow-up (Fig. 4).
Discussion
This study was conducted to evaluate the effects of
smoking on wound healing and scar formation assessed
by erythema measurements. The clinical impression that
smokers, although having increased risk of developing
wound complications, have better cosmetical appearing
scars and a diminished risk of hypertrophic scar formation
was confirmed by demonstrating decreased vascularity
reflected by the diminished redness of the scar. Although
the number of patients in the smoking group is small, the
diminished redness in this group was statistically clearly
demonstrated. It has been shown that the presence of scar
redness is correlated with the occurrence of hypertrophy.
Moreover, it has been considered to be associated with the
degree of elevation, hardening and retraction of the scar [5].
Smoking, therefore, might influence the risk of hypertro-
phy. Our hypothesis is that the mechanism by which this
happens is the same as the one responsible for the increased
wound complication rate in smokers: a deterioration of
proliferative and/or immunological response.
Smoking is one of the most important causes of
perioperative complications [6]. Postoperative complication
rates among smokers varies from 3.1 to 19% [7–10]. Most
of these wound complications consist of the development of
a postoperative infection and hematoma formation [6]. In a
well-performed recent study in breast reduction surgery, the
effect of smoking on wound complications was demon-
strated. An incidence of 40% in postoperative complica-
tions was seen among smokers proven by cotinine levels in
urine compared to 12% in nonsmokers [11]. In our study,
the overall incidence of postoperative complications was
Fig. 2 Redness measured postoperatively with the colorimeter at the
medial part of the scar. Significant difference after 3 months (p<0.005).
After 6 months, there was a slight difference in redness (p=0.066)
Fig. 1 Redness measured postoperatively with the colorimeter at the
lateral part of the scar. Significant difference in redness after 1 month
(p<0.01) and after 9 months (p<0.05)
Fig. 4 Redness measured postoperatively with the colorimeter at the
centeroftheinframammaryfold.Nosignificantdifferenceswerefoundin
the scar of the nipple. The differences in redness are p=0.116 after
1m o n t h ,p=0.209 after 3 months, p=0.107 after 6 months and p=0.575
after 9 months
Fig. 3 Redness measured postoperatively with the colorimeter at the
topmostpointofthenipple.Significantdifferenceafter1month(p<0.01)
and after 9 months (p<0.05)
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complications, which was defined quite broadly in our
study. Any wound defect until 3 months after surgery,
independent on size including, e.g., spitting of suture
material was defined as a wound complication. It is obvious
that measurement of redness was not performed at the sites
were there was or had been a wound dehiscence.
The pathological mechanism of an increased risk for
postoperative wound complications due to smoking can be
explained in several ways. One possible mechanism could be
through the changed availability of nitric oxide as is
hypothesized in the association between smoking and
vascular damage. Another possibility could be an altered
inflammatory response. Sorensen et al studied the effect of
smoking on wound healing [12]. The influx of macrophages
is shown to be less in smokers. Macrophages produce
proinflammatory cytokines that control adhesion and migra-
tion of inflammatory cells. Their subsequent proliferation is
triggered by multiple growth factors such as PDGF, EGF,
TGF-β, and cytokines IL-1 and TNF. A diminished number
of macrophages result in a disturbed cascade of this
inflammatory response.
Interestingly, the consequences of smoking on cytokines
and growth factors resulting in an increased risk of wound
complications may have a beneficial effect on scar
formation, resulting in cosmetically superior, less active
scars. It has been well established that in a normal situation
TGF-β causes fibroblast migration and proliferation,
increased synthesis of collagen and a decreased degradation
of extra cellular matrix (ECM) by metalloproteinases
needed for normal wound healing. In adults, the subclasses
TGF-β1 and TGF-β2 are mainly responsible for this effect.
In fetal healing, there is a low expression of TGF-β1 and
TGF-β2 and increased expression of TGF-β3 associated
with less visible scars [3, 13]. Therefore, the relative
concentrations of the several subclasses of TGF-β seem to
play an essential role in the appearance of scars. Smoking
has been shown to have an inhibiting effect on the influx of
macrophages, the initiators of the inflammatory cascade
and the subsequent production of TGF-β. The hypothesis
is that the relative contribution of TGF-β1 is less in
wounds of smokers, resulting in increased risk of compli-
cated wound healing but also resulting in cosmetically
better looking scars. In this line, it has been shown that
serum levels of TGF-β1 in nicotine-treated rats versus
saline-treated rats showed a significantly reduced serum
level of TGF-β1 [14].
In conclusion, we hypothesize that smoking alters the
inflammatory response resulting in more wound complica-
tions but also less active scarring. Without doubt, smoking
has severe adverse effects and creates a strong addiction
Therefore, it is absolutely not recommended as treatment.
However, our observations give rise to further exploration of
the pathofysiological effect that smoking and its specific
components may have on wound healing and scar formation.
This may eventually result in new ways to treat scars and
prevent wound complications.
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